Managing metabolic syndrome in women

Nurse Practitioner

Volumn 37, Issue 8, 2012, Pages 14-20

  Bosak, Kelly ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Cardiometabolic risk; Cost effectiveness; Gender related considerations; Metabolic syndrome; Prevention

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; FEMALE; HUMAN; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING; OBESITY; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; METABOLIC SYNDROME X; OBESITY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED STATES;

EID: 84866254267     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000415871.60058.69     Document Type: Article

References (39)

1. Xu JQ, Kochanek KD, Murphy SL. Deaths: Final Data for 2007: National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics; 2010.
2. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004;43(10):1791-1796.
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209.
4. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398.
5. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009;119(13): 1728-1735.
6. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. 2002. http://www.nhlbi.nih.gov/guidelines/cholesterol/ atp3-rpt.htm.
7. Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, D'Angostino RB. Trajectories of entering the metabolic syndrome: the Framingham Heart Study. Circulation. 2009;120(20):1943-1950.
8. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Risk of metabolic syndrome rises near menopause. Arch Intern Med. 2008;168(14):1568- 1575.
9. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update. Circulation. 2011;123(11):1243-1262.
10. Stern M P, Williams K, Gonzalez-Villalpando C, Hunt K J, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27(11):2676-2681.
11. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28(2):385-390.
12. Linton MF, Fazio S. A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol. 2003;92(1A):19i-26i.
13. Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. Br Med J. 1993;307(6915):1318-1322.
14. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81(4A):7B-12B.
15. Marma AK, Lloyd-Jones DM. Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile. Circulation. 2009;120:384-390.
16. Pencina MJ, D'Agostino RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119(24):3078-3084.
17. Vasan RS, Sullivan LM, Wilson PW, et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005;142(8):393-402.
18. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611-619.
19. Hartley LH, Lee I, eds. Exercise. Special Health Report. Boston, MA: Harvard Medical School; 2010.
20. Mosca L, Mochari-Greenbereger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3(2):120-127.
21. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105(3):310-315.
22. Conroy RM, Pyorala K, Fitzgerald A P, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987-1003.
23. Hertz R P, Unger AN, Cornell JA, Saunders, E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005; 165(18):2098-2104.
24. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin dependent diabetes. Atheroscler Thromb. 2002;12(12):1496-1502.
25. Turley ML, Skeaff CM, Mann JI, Cox B. The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride. Eur J Clin Nutr. 1998;52(10):728-732.
26. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. 2005. http://circ.ahajournals.org/cgi/content/full/112/17/e297.
27. Eckel RH, Grundy SM, Zimmer PZ. The metabolic syndrome. Lancet. 2005; 365(9468):1415-1428.
28. Boudreau DM, Malone DC, Raebel MA, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009;7(4):305-314.
29. Lavie CJ, Milani RV, O'Keefe JH. Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction. Am J Med Sci. 2011;341(5):388-393.
30. Bennett GG, Wolin KY, Puleo EM, Masse LC, Atienza A. Awareness of national physical activity recommendations for health promotion among US adults. Med Sci Sports Exerc. 2009;41(10):1849-1855.
31. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes. 2007;56():2655-2667.
32. Levine JA. Nonexercise activity thermogenesis (NEAT): environment and biology. Am J Physiol Endocrinol Metab. 2004;286(5):E675-E685.
33. Jilcott SB, Laraia BA, Evenson KR, Lowenstein LS, Ammerman AS. A guide for developing intervention tools addressing environmental factors to improve diet and physical activity. Health Promot Pract. 2007;8(2):192-204.
34. Bolin K, Lindgren B, Willers S. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. Chest. 2006;129(3):651-660.
35. Conn VS. Motivating people to move: exercise behavior research. West J Nurs Res. 2008;30(3):293-294.
36. Hertz R P, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165(18):2098-2104.
37. Ferris A, Robertson RM, Fabunmi R, Mosca L; American Heart Association; American Stroke Association. American Heart Association and American Stroke Association national survey of stroke risk awareness among women. Circulation. 2005;111(10):1321-1326.
38. Kleindorfer D, Khoury J, Broderick J P, et al. Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment. Stroke. 2009;40(7):2502-2506.
39. Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 suppl):29S-100S.